Daytime Sleepiness in Parkinson's Disease: Perception, Influence of Drugs, and Mood Disorder

M Ataide,C M R Franco,O G Lins,M. Ataide,C. M. R. Franco,O. G. Lins
DOI: https://doi.org/10.1155/2014/939713
2014-01-01
Sleep Disorders
Abstract:Parkinson's disease (PD) is associated with sleep complaints as excessive daytime sleepiness (EDS) and several factors have been implicated in the genesis of these complaints. Objective . To correlate the subjective perception of EDS with variables as the severity of the motor symptoms, medications, and the presence of depressive symptoms. Materials and Methods . A cross-sectional study, using specific scales as Epworth sleepiness scale (ESS), Beck depression inventory (iBeck) and Hoehn and Yahr (HY), in 42 patients with PD. Results . The patients had a mean age of 61.2 ± 11.3 years and mean disease duration of 4.96 ± 3.3 years. The mean ESS was 7.5 ± 4.7 and 28.6% of patients reached a score of abnormally high value ( > 10 ). There was no association with gender, disease duration, and dopamine agonists. Patients with EDS used larger amounts of levodopa ( 366.7 ± 228.0 versus 460.4 ± 332.25 mg, P = 0.038 ), but those who had an iBeck > 20 reached lower values of ESS than the others ( 5.9 ± 4.1 versus 9.3 ± 4.8 , P = 0.03 ). Conclusions . EDS was common in PD patients, being related to levodopa intake. Presence of depressed mood may influence the final results of self-assessment scales for sleep disorders.
What problem does this paper attempt to address?